Prognostic impact of serum CXC chemokine ligands 4 and 7 on myelodysplastic syndromes post allogeneic hematopoietic cell transplant

Leuk Lymphoma. 2021 Jan;62(1):229-233. doi: 10.1080/10428194.2020.1817446. Epub 2020 Sep 13.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Chemokines, CXC
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Ligands
  • Myelodysplastic Syndromes* / diagnosis
  • Myelodysplastic Syndromes* / therapy
  • Prognosis

Substances

  • Chemokines, CXC
  • Ligands